GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FIT Biotech Oy (OHEL:FITBIO) » Definitions » Beta

FIT Biotech Oy (OHEL:FITBIO) Beta : N/A (As of Jun. 19, 2024)


View and export this data going back to 2015. Start your Free Trial

What is FIT Biotech Oy Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-06-19), FIT Biotech Oy's Beta is Not available.


FIT Biotech Oy Beta Historical Data

The historical data trend for FIT Biotech Oy's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FIT Biotech Oy Beta Chart

FIT Biotech Oy Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17
Beta
- - - - -

FIT Biotech Oy Semi-Annual Data
Dec13 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18
Beta Get a 7-Day Free Trial Premium Member Only - - - - -

Competitive Comparison of FIT Biotech Oy's Beta

For the Biotechnology subindustry, FIT Biotech Oy's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


FIT Biotech Oy's Beta Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, FIT Biotech Oy's Beta distribution charts can be found below:

* The bar in red indicates where FIT Biotech Oy's Beta falls into.



FIT Biotech Oy Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


FIT Biotech Oy  (OHEL:FITBIO) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


FIT Biotech Oy Beta Related Terms

Thank you for viewing the detailed overview of FIT Biotech Oy's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


FIT Biotech Oy (OHEL:FITBIO) Business Description

Traded in Other Exchanges
N/A
Address
Biokatu 12, Tampere, FIN, FI-33520
FIT Biotech Oy is a clinical-stage biotechnology company. It is primarily focused on developing antibody therapies for cancer immunotherapy as well as Deoxyribonucleic acid (DNA) vaccines for the prevention of infectious diseases such as Human immunodeficiency virus (HIV). The firm's GTU technology enables the production of antibodies in the human body instead of using industrially manufactured antibodies. The GTU technology platform has various application areas. The group generates revenue through the sales of services related to the HIV vaccine. The organization is based in Finland.

FIT Biotech Oy (OHEL:FITBIO) Headlines

No Headlines